• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS Back to Search Results
Model Number 7277
Medical Device Problem Code High Readings (2459)
Health Effect - Clinical Code Lethargy (2560)
Date of Event 05/19/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The patient/family (a1) was the initial reporter (e1), so personal information was not entered.No information was captured in sections a2 and a4 as the customer's age and weight were not provided.
 
Event or Problem Description
The customer reported that he obtained a blood glucose reading of 442 mg/dl at 12:23 p.M.With the contour next gen meter and within two minutes, the reading with the laboratory testing was 200 mg/dl.The customer was feeling tired and associated the symptom with hyperglycemia.The customer was given metformin based on the laboratory test, and recovered well.There was no allegation of an adverse event.The customer was advised to return the device for evaluation.A replacement meter kit was sent to the customer.
 
Additional Manufacturer Narrative
The customer did not return the device for evaluation.Since the contour next test strips associated with the event expired in jun-2024, an in-house testing was not performed.A device history record was reviewed for the suspected contour next gen meter with serial # (b)(6), and no manufacturing anomalies were found.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR NEXT
Common Device Name
BLOOD GLUCOSE TEST STRIPS
Manufacturer (Section D)
ASCENSIA DIABETES CARE US INC.
100 summit lake drive
valhalla NY 10595
Manufacturer (Section G)
PHC CORPORATION (REGISTRATION NUMBER: 1000134386)
2131-1 minamigata
toon ehime, 791-0 395
JA   791-0395
Manufacturer Contact
shweta gulati
100 summit lake drive
valhalla, NY 10595
9142361830
MDR Report Key19499274
Report Number1810909-2024-00088
Device Sequence Number7925588
Product Code NBW
UDI-Device Identifier10301937277358
UDI-Public10301937277358
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K193407
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Remedial Action Replace
Type of Report Initial,Followup
Report Date (Section B) 05/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date06/30/2024
Device Model Number7277
Device Lot Number2FPEG41B
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 05/19/2024
Supplement Date Received by Manufacturer08/08/2024
Initial Report FDA Received Date06/10/2024
Supplement Report FDA Received Date08/21/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/01/2022
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Patient SexMale
-
-